References
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: HHLB/WHO, workshop report, http://www.ginasthma.com Updated 2006 Accessed: 16 December 2007
- Crompton G K. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis (suppl) 1982; 119: 101–104
- Lee H S. Proper aerosol inhalation technique for delivery of asthma medications. Clin Pediatr (Phila) 1983; 22: 440–443
- Newman S P, Weisz A W, Talaee N, Clarke S W. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712–716
- Newman S P. Scintigraphic assessment of therapeutic aerosols. Crit Rev Ther Drug Carrier Syst 1993; 10: 65–109
- Borgstrom L, Newman S, Weisz A, Moren F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J. Pharm Sci 1992; 81: 753–755
- Barry P W, O'Callaghan C. Inhalational drug delivery from seven different spacer devices. Thorax 1996; 51: 835–840
- Ahrens R, Lux C, Bahl T, Han S H. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995; 96: 288–294
- Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel M R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with a mask in younger children with airway obstruction. J Pediatr 1996; 128: 479–484
- Konig P. Spacer devices used with metered-dose inhalers. Breakthrough or gimmick?. Chest 1985; 88: 276–284
- Dolovich M B, Ahrens R C, Hess D R, Anderson P, Dhand R, Rau J L, Smaldone G C, Guyatt G. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335–371
- American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107–1136
- American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144: 1202–218
- Knudson R J, Lebowitz M D, Holberg C J, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725–734
- Musch W, Vincken W, Noppen M, Gorus F. Metabolic effects of inhaled fenoterol in normal subjects. Chest 1992; 102: 1099–1103
- Haalboom J R, Deenstra M, Struyvenberg A. Hypokalaemia induced by inhalation of fenoterol. Lancet 1985; 1: 1125–1127
- Whyte K, Addis G J, Whitesmith R, Reid J L. Adrenergic control of plasma magnesium in man. Clin Sci (Lond) 1987; 72: 135–138
- Brown M J, Brown D C, Murphy M B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 1983; 309: 1414–1419
- Struthers A D, Reid J L. Adrenaline causes hypokalaemia in man by β2-adrenoreceptors stimulation. Clin Endocrinol (Oxf) 1984; 20: 409–414
- Kung M. Parenteral adrenergic bronchodilators and potassium. Chest 1986; 89: 322–323
- Schmidt E W, Ulmer W T, Rominger K L. Pharmacokinetics and pharmacodynamics of beta 2-agonists (in the light of fenoterol). Respiration 1995; 62: 190–200
- Bennet A J, Tattersfield A E. Time course and relative potency of systemic effect from salmeterol and salbutamol in healthy subjects. Thorax 1997; 52: 458–464